Send feedback

CD99L2 p.Arg169Gln

c.506G>A · rs143706982 · VCV2342255

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.0832 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.046%, mid)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense0.0832likely benign
REVEL0.015strongly benign-leaning
SaProtLLR -7.59tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.98GERP -1.9
Regional constrainto/e 1.15unconstrained · MANE · 130 kb · p 0.025 · regional, not allelic
Overall
CADD2.58PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.046% Middle Eastern · 2/4,345 alleles
Filtering AF 0.0087% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00631%
Overall 0.00785% 95/1,209,673 alleles · ultra-rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.0728% 1,374
Middle Easterngrpmax 0.046% 2,173
East Asian 0.0178% 5,627
Admixed American 0.0175% 5,710
South Asian 0.0106% 9,448
African / African-American 0.0105% 9,559
Remaining individualsnot grpmax-eligible 0.00841% 11,897
Finnishnot grpmax-eligible 0.00645% 15,510
European (non-Finnish) 0.00492% 20,342

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CD99L2
Protein
p.Arg169Gln
Coding
c.506G>A
MANE Select
NM_031462
dbSNP
rs143706982
Type
single nucleotide variant
Location
chrX:150777473 (GRCh38)
Structure
AlphaFold pLDDT 55.71
Residue 169
the 'disordered' region
Full CD99L2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cd99l2-p-arg169gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown